Prostate cancer is a condition of public health significance in the United States. A new method for predicting survival is derived for the domain around the change point from a semiparametric ratio estimator (SPRE) to predict survival in response to treatment for prostate cancer. Using an extended maximum spacing estimator, the geometric mean of sample spacings from a uniform distribution ( , ) U u v is derived with known endpoints given at 0 and at the value of the change point from an ordinary least squares (OLS) regression for SPRE. To determine the maximum interval on the "x" axis between point estimates, the maximum spacing estimation method is derived from a continuous univariate distribution where spacing will be defined as gaps between ordered values of the distribution function. The maximum is defined as a single value in the neighborhood of the change point and spacing defined as a function of time. This maximum spacing defines the gaps between point estimates at each time-dependent predicted outcome from the change point and results in a semiparametric ratio estimator that is reliable and repeatable. Performance is discussed through a simulation of change point values for a real application in clinical medicine and, using SPRE, in personalized medicine for a single prostate cancer patient.
Introduction

Introduction to Prostate Cancer Survival Prediction
The motivation for this paper is to accurately predict survival in response to treatment for prostate cancer using a novel extended maximum spacing derivation to determine maximum time intervals between point estimates for a new semiparametric ratio estimator (SPRE) from Weissman-Miller (2013) . Maximum spacing is particularly important in predicting PSA levels or Gleason scores over time either in "watchful waiting" or in survival after treatment in prostate cancer. Since prostate cancer has a long natural history, accurate survival predictions may be important in determining treatment effectiveness. Prostate cancer is the most prevalent cancer of adult men in the United States (American Cancer Society, 2009 ) and Western Europe (Eton & Lepore, 2002) , and the second most common cause of cancer death after lung cancer according to Pastides (2001) . The National Cancer Institute estimates that there were 192,280 new cases of prostate cancer identified in the United States during 2009, and that 27,360 men will die of this cancer (National Cancer Institute, 2009 ). There are a number of treatment modalities currently available for prostate cancer according to Pastides (2001) , with new variations being tested in clinical trials all the time as noted by Eggener & Coleman (2008) and Tempany, Straus, Nabuhiko & Haker, (2008) . Options range from "watchful waiting" at the extreme low end of the intensity spectrum, to radical prostatectomy with orchiectomy or androgen deprivation and/or other chemotherapy, used for advanced disease, at the upper end of the intensity spectrum. Each treatment in this range has possible benefits, adverse effects and medical costs associated with it. The use of the SPRE model to predict patient survival after treatment can enhance the use of differing treatments that may optimize predicted survival. Since SPRE functions well as a single-subject design model as shown in Weissman-Miller, Shotwell and Miller (2012) and in Weissman-Miller (2013) ], SPRE can function as a "Personalized Medicine" model for survival prediction in prostate cancer.
Introduction to a Novel Prostate Cancer Survival Prediction
Long-term patient outcomes are predicted from short-term linear regression of initial patient"s data from a change point for a novel semiparametric ratio estimator (SPRE). The change point is the session number or time interval where the patient adapts to the treatment according to Weissman-Miller, et al (2012) . Then a novel extended maximum spacing estimate in the domain of the change point is derived to predict outcome spacing from the predictive distribution values relative to clinical test data. These estimates are on brachytherapy for prostate cancer from a survival analysis where the primary test data results are analysed using a Kaplan-Meier non-parametric method. The intent of this paper is to determine the maximum spacing of the predicted outcomes from the change point at 23 months to the 89 th month after treatment. The results relate very well to the original survival analysis data with an error of +/-1.15% at 89 months.
Method
The Statistical Method of the Change Point and Response Function in SPRE for Maximum Spacing
The extended maximum spacing is derived around the domain of the change point in the region from time 0 to the time at the change point of 23 months for Gleason score = 7 . In the SPRE model, the change point is derived from a backwards stepwise ordinary least squares regression, which provides minimum bias. The change point is determined from the highest or lowest F statistic given as
that is associated with the relevant distributional P-value (Weissman-Miller, 2013) 
, ( ) Weissman-Miller, 2013) . The step function is given here as for maximum spacing. It should be noted that the SPRE estimator is consistent at the beginning and end points of analysis, the upper and lower bounds, because it is unbiased at the change point and when the ratio 1.00 R  . Pilot studies for 13 -14 total therapy sessions where there is a low value of the change point, have shown an excellent relation of predicted to test data using in SPRE in occupational therapy for such areas as fall prevention in adults (Weissman-Miller & Graham, 2015) . A preliminary study for point estimations in prostate cancer survival from a higher value change point using varying maximum spacing was presented in Weissman-Miller (2011) . The importance of deriving accurate survival point estimations for prostate cancer cannot be overstated as prostate cancer has a long natural history and a timely prediction of survival may enable a tailored approach to prevention and care.
New Predictions for Maximum Spacing Estimation for the Model Data
The question now is -for predicting survival outcomes in prostate cancer, what is the statistically derived maximum spacing to use for point estimations from SPRE for a longer-term change point?
The maximum spacing estimation (MSE) in this paper is derived from the ordinary least squares (OLS) line from 0 to the value of the change point for the data at 23, in months, after which nonlinear point estimates are given by SPRE model. Since the change point is at some distance along the "x" axis from 0, the ratio of Weibull distributions as given by Weissman-Miller, et al (2012) and Weissman-Miller (2013) is shifted so that the maximum likelihood methods will fail. Therefore, an extended maximum spacing method is utilized in this paper to derive the equations for ( , ) U u v from which a value of v is specified as a reduced value, and is derived with a complementary value to the t i+1 t i+1 www.ccsenet.org/ijsp International Journal of Statistics and Probability Vol. 5, No. 2; 2016 21 originally derived equations. Then the maximum point estimate and spacing gap can be derived for the "x" axis. The original maximum spacing method used in this paper is based on the work by Cheng and Amin (1983) and Ranneby (1984) , with an extension to the method by Cheng and Stephens (1989) . In Ranneby"s method, an approximation to the Kullback-Leibler information is obtained by using spacing where each component is bounded from above. In general, the concepts underlying the MSE method are based on the probability integral transform at the "true parameter", where the "spacing" between each observation should be uniformly distributed. In this case, the implication is that the difference between the values of the cumulative distribution function at consecutive observations should be equal. This methodology has profound consequences for predicting outcomes of PSA or, in this paper, Gleason scores in prostate cancer. If the equal spacing of point estimates can be predicted over time using this method that maximizes the geometric mean of the spacing, then the "best fit" for these spacings is obtained. Using the following extended maximum spacing methods will ensure that the most reliable survival prediction can be made from the change point. A maximum spacing is derived on the "x" axis for predictions from the change point, as shown on Figure (Permission granted . Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy. BJU International; 94)
Definition of Spacings as
By spacings, we refer to the gaps (distances) between successive points on a line. The estimation of parameters is applied in any continuous univariate distribution. Following Cheng and Amin (1983) , this estimation of parameters is applied to a distribution with density ( , ) fx and CDF, ( , ) Fx . For a univariate distribution, let
be an ordered random sample of size "n" drawn from the distribution from smallest to largest. The initial spacings are the gaps between values of point estimations of the distribution function at adjacent ordered points. Then, following Cheng and Amin (1983) , Wong and Li (2006) and Ghosh & Jammalamadaka (2001) :
The original spacing function for ( , ) U u v may be given by:
In this paper, the following derivation of the univariate case is given from equation (2):
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International Journal of Statistics and Probability Vol. 5, No. 2; 2016 22 It should be noted that the analysis in this paper is aimed at defining the spacing on the "x" axis from the maximum spacing equations used to define the initial parameters. In this case, the original derivation should maximize the geometric mean of the spacing, where the geometric mean is given as the th n root of their product. Then the maximum spacing estimator of 0  is a value that maximizes the logarithm of the geometric mean of the sample spacing. For this analysis, the logarithm is given as the natural log, ln, which is often used in the spacing estimates for statistical entropy. In this sense, the message (in information theory) stands for an event, sample or character drawn from a distribution or data stream. In this analysis, any uncertainty characterized would relate to the disease process.
Derivation of the MSE and the Maximum Spacing of a Uniform Distribution
The maximum spacing estimator (MSE) of 0  is given as the argmax of the spacing function, where the argmax is defined as a point:
The maximum spacing is defined along this linear curve at the change point for the values of the Gleason score = 7 in the prostate cancer data that lie along the linear least squares regression line. The cumulative distribution function of the continuous uniform distribution is given as:
Then from equation (5), each discrete spacing is given by:
And:
2.4.1 Derivation for Parameters for the Extended Maximum Spacing Solution
In this extended analysis, the assumption is made that the values between spacing on the OLS line of values between 0 and 23 months are linear and assumed to be finite, and the additional assumption is made that the spacing between point estimations on the values of time for the Weibull ratio function are linear. The continuous uniform distribution ( , ) U u v fits these assumptions, such that for each member of the family all intervals of the same length are equally probable. The support is defined by the two parameters and uv , which are defined as the minimum and maximum values of the OLS line from 0 to the change point. Therefore, from values on the OLS line, an assumption is made that the maximum spacing estimates ( , ) U u v are known. For survival analysis, the extended derivation includes an unknown parameter (where a value of the initial parameter v is specified as a reduced value of the initial parameter) and given in this analysis as a function of () n x . Then () n x is initially defined as ( , ) nv x , the reduced value of the () n x variable expressed in terms of the v scale. However, the values in survival analysis descend from 1 to 0. Then the reduced value of v will be smaller than v . Thus, this value will be below the change point, as defined in Figure ( U u v continuous uniform distribution that is derived with respect to the change point, v , of the OLS linear regression analysis in SPRE, as defined in equation (7). As mentioned above, the maximum spacing estimator of 0  is a value that maximizes the logarithm of the geometric mean of the sample spacing. Therefore, statistic n S will be given here as:
The first 3 terms that depend upon , uvwill be differentiated resulting in a linear system. Solving yields the maximum spacing estimate (MSE) for , uvfollowing Cheng & Amin (1983) , derived to define ( , ) nv x at u and v:
, and
is the initial unknown parameter (9a.b)
The Extended Solution for the Maximum Spacing at the Change Point of the SPRE model
Solving for the extended solution involves 3 analytical steps.
Step 1 x is the minimum point estimation for the minimum variance unbiased estimators (MVUE) for the continuous distribution, the , uv outcomes are known at 0,0 and the change point respectively of the OLS line from the SPRE model, when "n" is the sample number of treatment data to the change point. In this analysis, the outcome for the endpoint u is known to be 1.00 at the initial data point of the OLS line, (Figure 1 ) where the value of (1) Step 2: To transpose ( , ) nv x to the "x" axis results in the point estimation of the number of months that yield the lower limit of the minimum-variance unbiased estimator (MVUE) maximum spacing on the "x" axis. The objective is to determine the reduced value from the change point, given here as () n x initially using the uniform distribution
and also denoted on the "x" axis:
Step 3: The final value of the spacing () sp x is given by the distance between () n x and the number of sample treatments to the change point where () n xn  on the "x" axis. Then:
In this extended maximum spacing method, n is known at the SPRE change point. From equation (14), the maximum spacing forward of the change point in the SPRE model = 1.1 on a finite number line. From equation (10a) Table 1 , will yield rounded identical maximum spacing results of () sp x = 1.00 at lower values of n = 20 -4. The overall result is important when the SPRE model is used to determine the maximum spacing in personalized medicine for values of the change point much lower than () n xn  23.
Simulations of the Continuous Uniform Distribution for 'n'at Varying Change Points
Since in this analysis n is a small number of months to the change point, a simulation has been conducted of the continuous uniform distribution in R with runif(n, min, max) when the default values are min = 0 and max = 1. These values are the lower and upper limits of the distribution, which must be finite. In this analysis, n = 23, the number of months of survival at the change point. Here, the mean = ½ for all the simulations, where the distribution of averages of 23 uniform distributions is investigated with 1000 simulations.
It can be seen that the theoretical mean is centered at 0.5, and the distribution of these sample means is centered at 0.4792. Where the distribution of averages of 10 uniform distributions is investigated with 1000 simulations, the distribution of the sample means = 0.4978, and for the distribution of averages of 5 uniform distributions the sample www.ccsenet.org/ijsp
International Journal of Statistics and Probability Vol. 5, No. 2; 2016 25 means = 0.5227. The comparative differences between these simulations of means and the theoretical means are 0.0416, 0.0044, and 0.0434 respectively. These differences are relatively small even at the very smallest value of n = 5, and negligible at n = 10. Therefore, the distribution of averages of uniform distributions may be considered to be stable for these values at the change point of the OLS linear regression, and the relatively small comparative differences indicate that the OLS can be modeled as the continuous uniform distribution ( , ) U u v . The results are given in Table 1 support earlier and ongoing pilot study data having change points from 4 -14 using a maximum spacing of 1.00. The values in Table 2 point to the use of varying maximum spacing for early, mid-term and very long-term values of the change point.
Results
An Important Consideration
It should be noted that the maximum spacing (MSE) is invariant with respect to the value of time on the OLS line because, as noted earlier, all intervals of the same length on the distribution"s support are equally probable. It should also be noted that the shape and scale parameters of the Weibull ratio are estimated from the OLS at the change point where the point estimates begin. Therefore, the maximum spacing will be used for all time values extending to the point estimates from   time at the change point to the asymptote for point estimates for prostate cancer. In Table 2, every  5 th point estimate is listed to summarize the estimated outcomes. 
Related values of Predictions to Test Data
The relative error from the final point estimate given in Table 1 to the data = 1.15%. This is an excellent result for point estimates given from the change point at 23 months to 89 months. The results are shown in Figure ( 3).
Discussion
"Modern transperineal brachytherapy techniques, using ultrasound guidance with either iodine-125 or palladium-103, offer good alternatives for the management of localized prostate cancer in appropriately selected patients," quoted from Potters (2003) . "For those men for whom watchful waiting is not an acceptable option, brachytherapy is the treatment that results in the least impairment of patient"s life-style and sexual function" (Potters, 2003) . As a result of these treatment methods, the use of maximum spacing derived from the extended MSE for the SPRE model becomes particularly important. This maximum spacing then defines the gaps between point estimates at each time-dependent predicted outcome from the change point forward and results in a semiparametric ratio estimator that is reliable and repeatable. This is important when the estimates are derived from a change point in short-term linear regression of the patients" data. The long-term predictions may extend out 7.42 years, when considering freedom from biochemical failure in prostate cancer given in this study. This analysis indicates that an important application of this extended maximum spacing estimator from the change point of the SPRE model is to predict the survival of prostate cancer patients in large-scale trials research, in clinical medicine or in personalized medicine. 
